Fascin enhances the vulnerability of breast cancer to erastin-induced ferroptosis

Cong Chen,Bojian Xie,Zhaoqing Li,Lini Chen,Yongxia Chen,Jichun Zhou,Siwei Ju,Yulu Zhou,Xun Zhang,Wenying Zhuo,Jingjing Yang,Misha Mao,Ling Xu,Linbo Wang

DOI: https://doi.org/10.1038/s41419-022-04579-1

2022-02-01

Cell Death and Disease

Abstract:Abstract Ferroptosis, which is characterized by intracellular iron accumulation and lipid peroxidation, is a newly described form of regulated cell death that may play a key role in tumour suppression. In the present study, we investigated the expression profiles and biological effects of fascin actin-bundling protein 1 (Fascin, gene name FSCN1 ) in breast cancer. In addition, bioinformatics analysis of the TCGA cancer database and gain- and loss-of-function studies showed that Fascin enhances sensitivity to erastin-induced ferroptosis. Mechanistically, Fascin directly interacts with cysteine/glutamate transporter (xCT, gene name SLC7A11 ) and decreases its stability via the ubiquitin-mediated proteasome degradation pathway. Furthermore, we observed that Fascin is substantially upregulated in tamoxifen-resistant breast cancer cell lines, and drug-resistant cells were also more vulnerable to erastin-induced ferroptosis. Taken together, our findings reveal a previously unidentified role of Fascin in ferroptosis by regulating xCT. Thus, ferroptosis activation in breast cancer with high Fascin level may serve as a potential treatment.

cell biology